Related Experiment Video
Updated: Jul 12, 2025

05:28
Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method
Published on: May 2, 2022
2.2K
The causality between gut microbiota and ankylosing spondylitis: Insights from a bidirectional two-sample Mendelian
Danyan Wang1, Rongqun Li1, Yue Jin1
1School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
International Journal of Rheumatic Diseases
|October 24, 2023
Summary
This study reveals a causal link between gut bacteria and ankylosing spondylitis (AS). Targeting specific gut microbes may offer new ways to prevent and treat AS.
Area of Science:
- Genetics
- Microbiology
- Immunology
Background:
- The relationship between gut microbiota and ankylosing spondylitis (AS) is suggested but not clearly established.
- Investigating this link is crucial for understanding AS pathogenesis.
Purpose of the Study:
- To determine the causal relationship between gut microbial composition and ankylosing spondylitis (AS) using a robust genetic approach.
- To identify specific gut bacteria that may influence AS risk.
Main Methods:
- A two-sample Mendelian randomization (MR) study utilized single nucleotide polymorphisms (SNPs) associated with gut microbiome and AS.
- Genome-wide association study data from 968 AS cases and 336,191 controls were analyzed.
- Inverse-variance weighted method was employed to estimate causal effects, with sensitivity analyses confirming robustness.
Main Results:
- Certain bacteria, including Anaerotruncus and Ruminococcaceae UCG002, showed a protective effect against AS.
- Conversely, Defluviitaleaceae, Butyricicoccus, Coprococcus 3, and Defluviitaleaceae UCG011 were associated with increased AS susceptibility.
- Reverse MR analysis indicated that AS does not influence gut microbial composition.
Conclusions:
- A genetically supported causal relationship between gut microbiota and AS has been established.
- These findings suggest potential therapeutic strategies targeting specific gut bacteria for AS prevention and treatment.

